Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Revelation Biosciences, Inc. (REVB) had Stock-Based Compensation of $0.22M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$2.10M |
|
$-2.10M |
|
$0.04M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.10M |
|
$-2.09M |
|
0.97M |
|
0.97M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$3.93M |
|
$0.04M |
|
$0.04M |
|
$3.97M |
|
$1.09M |
|
-- |
|
-- |
|
$1.09M |
|
$2.88M |
|
$2.88M |
|
$2.88M |
|
0.96M |
|
| Cash Flow Statement Financials | |
$-2.79M |
|
-- |
|
-- |
|
$6.50M |
|
$3.70M |
|
$-2.79M |
|
|
Stock-Based Compensation |
$0.22M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-71.20% |
|
-71.20% |
|
-51.66% |
|
-71.20% |
|
$2.99 |
|
$-2.88 |
|
$-2.88 |
|